Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
Author:
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2008.03309.x/fullpdf
Reference24 articles.
1. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome;Glueck;Metabolism,2003
2. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus;Ehrmann;Journal of Clinical Investigation,1995
3. The biological variation of insulin resistance in polycystic ovarian syndrome;Jayagopal;Journal of Clinical Endocrinology and Metabolism,2002
4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;ESHRE/ASRM-Sponsored_PCOS_Consensus_Workshop_Group;Fertility and Sterility,2004
5. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome;Jayagopal;Journal of Clinical Endocrinology and Metabolism,2005
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis;Clinical Endocrinology;2023-11-07
2. Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension;Neuro-Ophthalmology;2023-01-02
3. Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.;Al Mustansiriyah Journal of Pharmaceutical Sciences;2022-04-19
4. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials;Archives of Gynecology and Obstetrics;2022-04-18
5. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials;Clinical Endocrinology;2022-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3